Localization of mineralocorticoid receptor and 11 beta-hydroxysteroid dehydrogenase type II in human breast and its disorders

Anticancer Research

Volumn 17, Issue 3 C, 1997, Pages 2001-2007

  Sasano, Hironobu ^a   Frost, Andra R ^b   Saitohi, Ryuta ^a   Matsunaga, Gen ^a   Nagura, Hiroshi ^a   Krozowski, Zygmunt S ^c   Silverberg, Steven G ^b  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^c BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

11 Beta hydroxysteroid dehydrogenase; Breast; Cancer; Immunohistochemistry; Mineralocorticoid receptor

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; ALDOSTERONE; MINERALOCORTICOID RECEPTOR;

ARTICLE; BREAST CANCER; BREAST DUCT; BREAST EPITHELIUM; BREAST FIBROADENOMA; BREAST LESION; CANCER INFILTRATION; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME LOCALIZATION; FIBROCYSTIC BREAST DISEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECEPTOR AFFINITY;

11-BETA-HYDROXYSTEROID DEHYDROGENASES; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BREAST; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; FEMALE; FIBROADENOMA; FIBROCYSTIC BREAST DISEASE; HUMANS; HYDROXYSTEROID DEHYDROGENASES; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; RECEPTORS, ESTROGEN; RECEPTORS, MINERALOCORTICOID; REFERENCE VALUES;

EID: 0030878966     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Marver D, Kukko JP: Renal target sites and the mechanism of action of aldosterone. Mineral Electrolyte Metabolism 9: 1-18, 1983.
2. Sasano H, Fukushima K, Sasaki I, Matsuno S, Nagura H, Krozowski ZS: Immunolocalization of mineralocorticoid receptor in human kidney, pancreas, salivary, mammary and sweat glands: a light and electron microscopic immunohistochemical study. J Endocrinology 132: 305-310, 1992.
3. Edwards CR, Stewart PM, Burt D, Brett L, McIntyre MA, Sutanto WS, deKloet ER, Monder C: Localization of 11 B-hydroxysteroid dehydrogenase-tissue specific protector of the mineralocorticoid receptor. Lancet. 2: 986-989, 1988.
4. Funder JW, Pearce PT, Smith R, Smith Al: Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated Science. 242: 583-585, 1988.
5. Krozowski Z, Maguire JA, Stein-Oakley AN, Dowling J, Smith RE, Andrews RK.: Immunohistochemical localization of the 11β- hydroxysteroid dehydrogenase type II enzyme in human kidney and placenta. J Clin Endocrinol Metab 80: 2203-2209, 1995.
6. Sasano H, Sasano N: Immunohistochemical demonstration of steroid C21 hydroxylase in normal and neoplastic human breasts. Cancer 62: 1183-1187, 1988.
7. Quirk SJ, Gannell JE, Funder JW.: Aldosterone-binding sites in pregnant and lactating rat mammary glands. Endocrinology 113: 1812-1817, 1983.
8. Quirk SJ, Slattery JA, Funder JW.: Epithelial and adipose cells isolated from mammary glands of pregnant and lactating rats differ in 11 B- hydroxysteroid dehydrogenase activity. J Steroid Biochem Molec Biol 37: 529-534, 1990.
9. Smith RE, Maguire JA, Stein-Oakley AN, Sasano H, Takahashi K, Fukushima K, Krozowski ZS: Localization of 11 B-hydroxysteroid dehydrogenase type II in human epithelial tissues. J Clinical Endocrinol Metab, in press.
10. Martin PM, Rolland PH, Raynaud J-P.: Macromolecular binding of dexamethasone as evidence for the presence of mineralocorticoid receptor in human breast cancer. Cancer Res 41: 1222-1226, 1981.
11. Sasano H, Nagura H, Harada N, Goukon Y, Kimura M.: Immunolocalization of aromatase and other steroidogenic enzymes in human breast disorders. Hum Pathol 25: 530-535, 1994
12. Sasano H, Kimura M, Shizawa S, Kimura N, Nagura H: Aromatase and steroid receptor in gynecomastia and male breast carcinoma: An immunohistochemical study. J Clinical Endocrinol Metab. in press.
13. Albiston AL, Obeyesekere VR, Smith RE, Krozowski ZS: Cloning and tissue distribution of the human 11β-hydroxysteroid dehydrogenase type 2 enzyme. Mol Cell Endocrinol 105: R11-R17, 1994.
14. Rusvai E, Naray-Fejes-Toth A.: A new isoform of 11-beta- hydroxysteroid dehydrogenase in aldosterone target cells. J Biol Chem 268: 10717-10720, 1993.
15. Kenouch S, Alfaidy N, Bonvalet JP, Farman N: Expression of 11- beta-OHSD along the nephron of mammals and humans. Steroids 59: 100-104, 1994.
16. Albiston AL, Smith RE, Krozowski ZS: Sex- and tissue-specific regulation of 11β-hydroxysteroid dehydrogenase mRNA. Mol Cell Endocrinol 109: 183-188, 1995.
17. Page DL, Andersen TJ: Stages of breast development in Diagnostic Histopathology of the Breast. (ed) Page DL, Anderson TJ, pp11-29, Churchill Livingstone Edinburgh, London, Melbourne, New York, 1989.
18. Fukushima K, Sasano H, Nagura H, Sasaki I, Matsuno S, Krozowski Z: Immunohistochemical localization of mineralocorticoid receptor in the human gut. Tohoku J Exp Med 165: 155-163, 1991.
19. Kenouch S, Lombes M, Delahaye F, Eugene E, Bonvalet JP, Farman N: Human skin as target for aldosterone: Coexpression of mineralocorticoid receptors and 11β-hydroxysteroid dehydrogenase. J Clin Endocrinol Metab 79: 1334-1341, 1994.
20. Allegra JC, Lippman ME, Thomson EB, Simon R, Barlock A, Green L, Huff KK, Do HMT, Aitken SC: Relationship between the progesterone, androgen, and glucocorticoid receptors and response rate to endocrine therapy in metastatic breast cancer. Cancer Res 39: 1973-1979, 1979.
21. Allegra JC, Lippman ME, Thomson EB, Simon R, Barlock A, Green L, Huff KK, Do HMT, Aitken S: Distribution, frequency and quantitative analysis of estrogen, progesterone, androgen and glucocorticoid receptors in human breast cancer. Cancer Res 39: 1447-1454, 1979.
22. McGuire WL, Pearson OH, Segaloff A: Predicting hormone responsiveness in human breast cancer. In: W.L. McGuire, P.P. Carbone, and E.P. Vollmer (eds.), Estrogen Receptors in Human Breast Cancer, New York: Raven Press, pp. 17-30, 1975.
23. Lloveras B, Edgerton S, Thor AD: Evaluation of in vitro bromodeoxyuridine labeling of breast carcinomas with the use of a commercial kit. Am J Clin Pathol 95: 41-47, 1991.
24. MacDevitt RW, Stone KR, Craig RB, Meyer JS: A comparison of human breast cancer cell kinetics measured by flow cytometry and thymidine labeling. Iab Invest. 52: 287-291, 1985.
25. Meyer JS, Friedman E, McCrate MM, Bauer WC: Prediction of early course of breast carcinoma by thymidine labeling. Cancer 51: 1879- 1886, 1983.
26. Dixon JM, Anderson TJ, Page DL, Lee D, Duffy SW, Stewart HJ: Infiltrating lobular carcinoma of the breast: an evaluation of the incidence and consequence of bilateral disease. Br J Surg 70: 515-516, 1983.
27. Moll R, Mitze M, Frixen UH, Birchmeier W: Differential loss of E- cadherin expression in infiltrating ductal and lobular breast carcinomas. Am J Pathol 143: 1731-1742, 1993.
28. Martinazzi M, Crivelli F, Zampatti C, Martinazzi S: Epidermal growth factor receptor immunohistochemistry in different histological types of infiltrating breast carcinoma. J Clin Pathol 46: 1009-1010, 1993.
29. Marchetti A, Buttitta F, Pellegrini S, Campani D, Diella F, Cecchetti D, Callahan R, Bistocchi M: p53 mutations and histological type of invasive breast carcinoma. Cancer Res 53: 4665-4669, 1993.
30. Sasano H, White PC, New Ml, Sasano N: Immunohistochemistry of cytochrome P450 21-hydroxylase Microscopic examination of the enzyme in bovine adrenal cortex and kidney. Endocrinology 122: 291- 295, 1988.
31. Sasano H, Ohkubo T, Sasano N.: Immunohistochemical demonstration of steroid C-21 hydroxylase in normal and neoplastic salivary glands. Cancer 61: 750-753, 1988.
32. McCarty KS Jr, McCarty KS Sr.: Steroid hormone receptor in the regulation of differentiation. Am J Pathol 86: 705-744, 1977.